Gastrointestinal stoma complication
(UMLS:C1696157)
- UMLS ID:
- C1696157
- MeSH ID:
- N/A
Synonym(s)
1.
Gastrointestinal stoma complication
Associated Drug(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Isotretinoin | FAERS: 41 | US FAERS | |
| 2 | carbidopa, levodopa drug combination | FAERS: 34 | US FAERS | |
| 3 | teduglutide | FAERS: 22 | SIDER US FAERS | |
| 4 | Metformin | FAERS: 11 | US FAERS | |
| 5 | niraparib | FAERS: 11 | US FAERS | |
| 6 | Octreotide | FAERS: 9 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 7 | Capecitabine | FAERS: 7 | US FAERS | |
| 8 | Lenalidomide | FAERS: 5 | US FAERS | |
| 9 | Cabozantinib S-malate | FAERS: 3 | US FAERS | |
| 10 | Fluorouracil | FAERS: 3 | OFFSIDES US FAERS | |
| 11 | Sorafenib | FAERS: 3 | US FAERS | |
| 12 | 4-Aminopyridine | FAERS: 2 | US FAERS | |
| 13 | Aripiprazole | FAERS: 2 | US FAERS | |
| 14 | Metformin | FAERS: 2 | US FAERS | |
| 15 | NuvaRing | FAERS: 2 | US FAERS | |
| 16 | Paliperidone Palmitate | FAERS: 2 | US FAERS | |
| 17 | Rivaroxaban | FAERS: 2 | US FAERS | |
| 18 | lanreotide | FAERS: 2 | US FAERS | |
| 19 | pazopanib | FAERS: 2 | US FAERS | |
| 20 | Barium Sulfate | FAERS: 1 | US FAERS | |
| 21 | Breo Ellipta | FAERS: 1 | US FAERS | |
| 22 | Cinacalcet | FAERS: 1 | US FAERS | |
| 23 | Cisapride | FAERS: 1 | US FAERS | |
| 24 | Desvenlafaxine Succinate | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 25 | Dimethyl Fumarate | FAERS: 1 | US FAERS | |
| 26 | Doxepin | FAERS: 1 | US FAERS | |
| 27 | Erlotinib Hydrochloride | FAERS: 1 | US FAERS | |
| 28 | Esomeprazole | FAERS: 1 | US FAERS | |
| 29 | Fentanyl | FAERS: 1 | US FAERS | |
| 30 | Ferric Oxide, Saccharated | FAERS: 1 | US FAERS | |
| 31 | Fosamax plus D | FAERS: 1 | US FAERS | |
| 32 | Gabapentin | FAERS: 1 | US FAERS | |
| 33 | Imatinib Mesylate | FAERS: 1 | US FAERS | |
| 34 | Imatinib Mesylate | FAERS: 1 | US FAERS | |
| 35 | Morphine | FAERS: 1 | US FAERS | |
| 36 | Olanzapine | FAERS: 1 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 37 | Omeprazole | FAERS: 1 | US FAERS | |
| 38 | Paclitaxel | FAERS: 1 | US FAERS | |
| 39 | Pantoprazole | FAERS: 1 | US FAERS | |
| 40 | Ribavirin | FAERS: 1 | US FAERS | |
| 41 | Sitagliptin Phosphate | FAERS: 1 | US FAERS | |
| 42 | Sunitinib | FAERS: 1 | US FAERS | |
| 43 | Tacrolimus | FAERS: 1 | US FAERS | |
| 44 | Teriparatide | FAERS: 1 | US FAERS | |
| 45 | Tigecycline | FAERS: 1 | US FAERS | |
| 46 | Valproic Acid | FAERS: 1 | US FAERS | |
| 47 | Warfarin | FAERS: 1 | US FAERS | |
| 48 | alvimopan | FAERS: 1 | US FAERS | |
| 49 | lanreotide | FAERS: 1 | US FAERS | |
| 50 | lanreotide | FAERS: 1 | US FAERS | |
| 51 | macitentan | FAERS: 1 | US FAERS | |
| 52 | regorafenib | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 53 | Amitriptyline | OFFSIDES | ||
| 54 | Beclomethasone | OFFSIDES | ||
| 55 | Bisacodyl | OFFSIDES | ||
| 56 | Butylscopolammonium Bromide | OFFSIDES | ||
| 57 | Caspofungin | OFFSIDES | ||
| 58 | Cefotaxime | OFFSIDES | ||
| 59 | Cinacalcet | OFFSIDES | ||
| 60 | Clotrimazole | OFFSIDES | ||
| 61 | D-Galactosamine | OFFSIDES | ||
| 62 | Diphenoxylate | OFFSIDES | ||
| 63 | Ertapenem | SIDER | ||
| 64 | Leucovorin | OFFSIDES | ||
| 65 | Linezolid | OFFSIDES | ||
| 66 | Losartan | OFFSIDES | ||
| 67 | Meperidine | OFFSIDES | ||
| 68 | Metoclopramide | OFFSIDES | ||
| 69 | Nitrazepam | OFFSIDES | ||
| 70 | Nitric Oxide | OFFSIDES | ||
| 71 | Piperacillin, Tazobactam Drug Combination | OFFSIDES | ||
| 72 | Piperacillin | OFFSIDES | ||
| 73 | Thyroxine | OFFSIDES | ||
| 74 | Tobramycin | OFFSIDES | ||
| 75 | Travoprost | OFFSIDES | ||
| 76 | Tretinoin | OFFSIDES | ||
| 77 | Zinc Sulfate | OFFSIDES | ||
| 78 | alvimopan | OFFSIDES | ||
| 79 | chlordiazepoxide, clidinium drug combination | OFFSIDES |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.